Lumexa Imaging Holdings, Inc. Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions
Lumexa Imaging Holdings, Inc. (LMRI) had Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions of 100.00% as of 2025-12-10, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Equity
us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions · last filed 2026-08-13
- 2025-12-10: Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 100.00%.
| Period end | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions |
|---|---|
| 2025-12-10 | 100.00% 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |